Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019

J. Betancourt-Peña (Cali, Colombia), D. Escobar-Vidal (Cali, Colombia), J. Rodriguez-Castro (Cali, Colombia), D. Guerrero Jaramillo (Cali, Colombia), V. Benavides Córdoba (Cali, Colombia)

Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Session: Epidemiology and understanding of airways diseases in primary care
Session type: E-poster session
Number: 2407
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Betancourt-Peña (Cali, Colombia), D. Escobar-Vidal (Cali, Colombia), J. Rodriguez-Castro (Cali, Colombia), D. Guerrero Jaramillo (Cali, Colombia), V. Benavides Córdoba (Cali, Colombia). Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019. 2407

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adherence to GOLD guidelines practices in the management of COPD in  Tunisia
Source: International Congress 2018 – COPD around the world
Year: 2018


Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

GOLD recommendations for COPD management
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014



Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015

High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013


Prevalence of Poor Disease Control in Patients with severe COPD according to GOLD 2021
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015



Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Monitoring COPD patients according to the GOLD 2017 document: systemic and bronchial inflammation.
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Prevalence and severity of GOLD defined COPD in adults
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002

COPD GOLD 2017 guidelines adherence in Swiss pulmologists and general practitioners
Source: International Congress 2018 – Primary care management of COPD
Year: 2018